*Correspondence: vizzardi72@gmail.com (Enrico Vizzardi)
† These authors contributed equally.
Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019
(COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the
major clinical manifestation. The exact incidence of thromboembolic events is
largely unknown, so that a relative significant number of studies have been
performed in order to explore thrombotic risk in COVID-19 patients. Cytokine
storm, mediated by pro-inflammatory interleukins, tumor necrosis factor